First patient treated in the second dose group in Annexin`s RVO study
25 Oct 2023 //
PR NEWSWIRE
Annexin announces success in the company`s cancer initiative
29 Sep 2023 //
PR NEWSWIRE
Promising signals of effect in Annexin`s RVO-study
11 Aug 2023 //
PR NEWSWIRE